Clinical Trial Update: The Prospective Evaluation of Peri-Operative Glucocorticoid Use in the Management of Cervicofacial Infections of Odontogenic Origin [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating peri-operative glucocorticoids for cervicofacial odontogenic infections, completed in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Odontogenic Infection of the Jaw

Snippet

Sponsor: University of Manitoba | Conditions: Odontogenic Infection of Jaw (Disorder) | Phase 2, Phase 3 | Status: COMPLETED